Today: 12 June 2026
Red Robin Shares Rise After Earnings Beat

Red Robin Shares Rise After Earnings Beat

NEW YORK, May 19, 2026, 18:03 EDT

Red Robin Gourmet Burgers shares rose in after-hours trading Tuesday. The burger chain beat analysts’ revenue estimates and reaffirmed its 2026 outlook. Still, first-quarter sales and traffic both declined from last year.

The stock finished the regular Nasdaq session at $3.85, gaining 2.7%. After hours, shares traded at $4.45, up 15.6%, according to Webull at 18:03 EDT. Regular session volume hit 2.98 million shares, much higher than the recent average on the same market-data page.

Red Robin is still a small-cap with valuation at about $69.8 million at the close. That keeps the shares reactive to early evidence that value deals, traffic pushes, and cost cuts are sticking.

Red Robin posted first-quarter revenue of $378.3 million, down from $392.4 million a year ago. Net loss came in at $2.2 million, or 12 cents a share. Adjusted EPS was 13 cents. The Fly, via TipRanks, noted revenue topped the $362.14 million consensus estimate. Red Robin Gourmet Burgers, Inc.

Red Robin Gourmet Burgers, Inc. said comparable restaurant revenue—covering company-run locations open at least 18 months and not counting deferred loyalty revenue—slipped 0.6%. Guest traffic was off 1.6%. Average check per guest was up 1.0%.

Red Robin CEO Dave Pace said the company saw “continued progress in traffic trends and restaurant-level profitability.” Pace cited its First Choice plan, the new menu, and targeted marketing as key parts of that. He also said the Big Yummm value platform helped boost guest engagement. Red Robin Gourmet Burgers, Inc.

Margins ticked higher and caught investors’ attention. Restaurant-level operating profit margin was up 50 basis points at 14.8%. That figure strips out corporate costs. A basis point equals one-hundredth of a percentage point.

Red Robin’s adjusted EBITDA fell 2.1% to $27.3 million. The company blamed higher marketing spending, which was only partly offset by reduced general and administrative expenses.

Red Robin Gourmet Burgers, Inc. kept its fiscal 2026 guidance unchanged. The company is still looking for comparable restaurant revenue growth between 0.5% and 1.5%, restaurant-level operating profit near 13%, and adjusted EBITDA of $70 million to $73 million. Expected capital spending stays in the $25 million to $30 million range.

Red Robin is “maintaining the full year guidance for 2026,” CFO Mark Graff said on the earnings call, noting the outlook excludes any impact from the company’s tactical refranchising efforts. CEO G.J. Pace told analysts Red Robin is in final talks with several possible franchisees and plans to put any proceeds from refranchising toward paying down debt. The Motley Fool

Rivals aren’t idle. Late last month, Brinker International said Chili’s same-store sales were up 4.0% last quarter, crediting menu innovation, value deals and ads. BJ’s Restaurants showed 2.4% comps growth, driven mostly by a 2.2% bump in guest traffic. Red Robin’s drop in traffic stands out as something it needs to fix. PR Newswire

Risks are still out there. Red Robin reported a net loss and a drop in comparable sales, as traffic slipped. Margin gains could get hit if its value deals fail to pull in enough guests. Graff said about 60% of 2026 commodity needs are locked, but beef and dairy mostly aren’t hedged yet—that could keep food costs volatile. Red Robin Gourmet Burgers, Inc.

Red Robin Gourmet Burgers, Inc. wrapped up the quarter with $175.7 million drawn on its credit facility and had around $40.8 million in liquidity, counting both cash and what was left to borrow. Shares moved sharply after the bell. The next thing to watch is if Wednesday’s trading keeps that move going.

Stock Market Today

  • IFCI shares surge 20% as NSE prepares to file DRHP next week
    June 12, 2026, 7:45 AM EDT. IFCI shares hit a 20% upper circuit limit following news that the National Stock Exchange (NSE) is likely to file a Draft Red Herring Prospectus (DRHP) next week. A DRHP is a preliminary registration document companies submit before an initial public offering (IPO). This regulatory step often signals upcoming market activity, prompting sharp stock movements. The surge reflects investor anticipation of the NSE's IPO plans. Market participants are advised to monitor developments closely for further clarity on issuance details.

Latest articles

EchoStar Stock Rallies as SpaceX IPO Puts SATS’ Spectrum Bet Back in Focus

EchoStar Stock Rallies as SpaceX IPO Puts SATS’ Spectrum Bet Back in Focus

12 June 2026
EchoStar surged 11.19% to $128.13 and jumped another 5.48% premarket as investors bet on the value of SpaceX shares EchoStar will receive in a $17 billion spectrum deal, but risks remain with a $183 million deferred interest payment and core revenue falling to $3.67 billion from $3.87 billion, leaving the stock near its 52-week high and dependent on SpaceX’s IPO debut and deal completion.
Grab Shares Up Off Lows as Investors Watch Taiwan Deal Test

Grab Shares Trade Near Year Low Ahead of Earnings

12 June 2026
Grab shares closed at $3.35, up 2.45% but still near a 52-week low, as investors await August’s Q2 results call when the company will update financial guidance after consolidating Indonesia’s Superbank, a move seen as the next major catalyst for the stock.
Oracle Drops After Surprise AI Costs Challenge Cloud Narrative

Oracle Drops After Surprise AI Costs Challenge Cloud Narrative

12 June 2026
Oracle shares plunged 12% after record Q4 results as investors focused on negative $23.7 billion free cash flow, $43 billion in new debt, and plans to raise $40 billion more to fund AI data-center growth, despite 93% OCI revenue growth and a $638 billion backlog; the next catalyst is proof that heavy AI spending will generate revenue and margins.
Exxon, Chevron Say Oil Reserves Hit by Hormuz Choke, More Volatility Ahead
Previous Story

Exxon, Chevron Say Oil Reserves Hit by Hormuz Choke, More Volatility Ahead

SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus
Next Story

SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

Go toTop